List of Oncology Medication For

Chronic Disease

Specialty medications are used to treat patients with complex and/or rare diseases; have special dosage, storage, handling, and administration requirements; and require high touch patient care and monitoring services (eg, transplant, oncology, MS, hepatitis).

Cysteamine Bitartrate Capsules

Chronic Disease

cysteamine bitartrate
delayed-release capsules, for oral use

cysteamine bitartrate is a cystine-depleting agent indicated for the treatment of nephropathic cystinosis in adult and pediatric patients 2 years of age and older. Cysteamine is used to treat cystinosis. It is available by mouth (capsule and extended release capsule) and in eye drops.

Facts about cysteamine bitartrate capsules

Approval Date: 1991
Proprietary Name: PROCYSBI (cysteamine bitartrate)
Active Ingredient(s): cysteamine bitartrate
Dosage Forms And Strengths: Delayed-release capsules: 25 mg and 75 mg
Medicine Approved By: Food and Drug Administration (FDA)
Manufacturer: Bayer Pharmaceuticals In
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “cysteamine bitartrate capsules” based on the information you provide.

Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India. With over two decades of industry experience, IPN offers extensive coverage across India, including prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

DEFENCATH (taurolidine, heparin) Solution

Kidney

Brand Name: DEFENCATH Generic Name: (taurolidine, heparin)
DEFENCATH (taurolidine, heparin) is used to reduce the incidence of catheter-related bloodstream infections in adults with kidney failure receiving chronic hemodialysis through a central venous catheter.

The U.S. Food and Drug Administration has approved Defencath (taurolidine and heparin) catheter lock solution (CLS) to reduce catheter-related bloodstream infections in adult patients with kidney failure who are receiving chronic hemodialysis (HD) through a central venous catheter (CVC). Defencath is indicated in this limited and specific patient population.

Defencath CLS is available as a sterile, preservative-free, clear, aqueous-based solution in 3ml and 5ml dosages

Brand Name:	DEFENCATH
Generic Name:	(taurolidine, heparin)
Strength:	DEFENCATH is a sterile catheter lock solution available in single dose vials in the following strengths: 3 mL containing taurolidine 40.5 mg/3 mL (13.5 mg/mL), and heparin 3,000 USP Units/3 mL (1,000 USP Units/mL 5 mL containing taurolidine 67.5 mg/5 mL (13.5 mg/mL), and heparin 5,000 USP Units/5 mL (1,000 USP Units/mL)
Manufacturer:	CorMedix Inc.
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “DEFENCATH (taurolidine, heparin)” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for DEFENCATH (taurolidine, heparin) price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

Difelikefalin Injection

Kidney

KORSUVA (difelikefalin) injection,
for intravenous use Initial U.S. Approval: 2021

KORSUVA is a kappa opioid receptor agonist indicated for the treatment of moderate-to-severe pruritus associated with chronic kidney disease (CKD-aP) in adults undergoing hemodialysis (HD). KORSUVA (difelikefalin) is a kappa opioid receptor agonist. Difelikefalin is a synthetic peptide with a single stereoisomer and is present as an acetate salt.

Facts about difelikefalin Injection

Approval Date: 2021
Proprietary Name: On Request
Active Ingredient(s): pruritus associated with chronic kidney disease (CKD-aP)
Dosage Forms And Strengths: Injection: 65 mcg /1.3 mL (50 mcg/mL) of difelikefalin.
International non-proprietary name (INN) or common name: difelikefalin injection
Therapeutic area (MeSH): moderate to severe itching
Marketing: Vifor (International) Inc.
EMA Approved: 2021
Summary of FDA approved use on approval date: Click Here

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import difelikefalin injection” based on the information you provide.

Dulaglutide Injection

Diabetes

dulaglutide injection
for subcutaneous use Initial U.S. Approval: 2014

Facts about dulaglutide injection

Approval Date: 2014
Proprietary Name: On Request
Active Ingredient(s): dulaglutide
Dosage Forms And Strengths: Injection: 0.75 mg/0.5 mL solution in a single-dose pen
Injection: 1.5 mg/0.5 mL solution in a single-dose pen
Injection: 0.75 mg/0.5 mL solution in a single-dose prefilled syringe
Injection: 1.5 mg/0.5 mL solution in a single-dose prefilled syringe
Company: Eli Lilly
Diseases: Type 2 diabetes, cardiovascular risk reduction
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “dulaglutide injection” based on the information you provide.

EGRIFTA WR (tesamorelin) for injection

Chronic Disease, HIV

Brand: EGRIFTA WR. API: tesamorelin is used to treat HIV-infected adults with lipodystrophy.

Egrifta WR (tesamorelin) is a prescription medicine used to reduce excess visceral abdominal fat (stomach-area fat) in HIV-infected adults with lipodystrophy.

Brand Name:	EGRIFTA WR – On Request
Generic Name:	tesamorelin
Strength:	For injection: 11.6 mg of tesamorelin as a lyophilized powder in single patient-use vial for reconstitution.
Manufacturer:	THERA.
Approved By:	EMA, USFDA
Get access to medicines:	In India
Price:	On Request

See full prescribing information for EGRIFTA WR : Patient Information

Get access EGRIFTA WR to treat HIV-infected adults with lipodystrophy on a Named Patient Import Basis.

IPN, New Delhi serves as a facilitator for the procurement of specialized drugs on behalf of patients or treating doctors, enabling access to EGRIFTA WR (tesamorelin) for personal use. To proceed, the applicant must submit an application in Form 12A along with a valid prescription issued by a Registered Medical Practitioner (RMP).

For any queries, including information regarding the cost of the pharmaceutical product in India, please contact the IPN Healthcare Support Team via email or at the following numbers: Mobile/WhatsApp: Mr. Tarun: +91 9891 296 838 | Mr. Neeraj: +91 9811 747 774.

ELAHERE (mirvetuximab soravtansine-gynx) injection

Ovarian, Chronic Disease

ELAHERE (mirvetuximab soravtansine-gynx) – folate receptor-alpha positive ovarian cancer, fallopian tube cancer, or primary peritoneal cancer therapy in India

ELAHERE is a prescription medicine used to treat adults with folate receptor-alpha positive ovarian cancer, fallopian tube cancer, or primary peritoneal cancer.

Brand Name:	ELAHERE
Generic Name:	mirvetuximab soravtansine-gynx
Strength:	• Injection: 100 mg/20 mL (5 mg/mL) in a single-dose vial.
Manufacturer:	ImmunoGen
Approved By:	EMA, USFDA

Source Details: Patient Information
ELAHERE must always be used under the supervision of a Registered Medical Practitioner (RMP).

Access ELAHERE for ovarian cancer, fallopian tube cancer, or primary peritoneal cancer treatment on a Named Patient Import Basis

IPN, New Delhi serves as a facilitator for the procurement of specialized drugs on behalf of patients or treating doctors, enabling access to ELAHERE (mirvetuximab soravtansine-gynx) for personal use. To proceed, the applicant must submit an application in Form 12A along with a valid prescription issued by a Registered Medical Practitioner (RMP).

Note: All access is provided strictly on a Named Patient Import Basis and for personal use only, in accordance with Indian regulatory guidelines.

Empagliflozin and Linagliptin Tablets

Diabetes

empagliflozin and linagliptin tablets
for oral use Initial U.S. Approval: 2015

Facts about empagliflozin and linagliptin tablets

Approval Date: 2015
Proprietary Name: GLYXAMBI (empagliflozin and linagliptin) tablets
Active Ingredient(s): empagliflozin and linagliptin
FDA-approved use:
Dosage Form: Tablets: • 10 mg empagliflozin/5 mg linagliptin • 25 mg empagliflozin/5 mg linagliptin
Medicine Approved By: Food and Drug Administration (FDA)
Manufacturer: Boehringer Ingelheim Pharmaceuticals, Inc
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “Empagliflozin and Linagliptin Tablets” based on the information you provide.

Ertugliflozin Tablets

Diabetes

ertugliflozin tablets
for oral use Initial U.S. Approval: 2017

STEGLATRO is a sodium glucose co-transporter 2 (SGLT2) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Facts about ertugliflozin tablets

Approval Date: 2017
Proprietary Name: STEGLATRO (ertugliflozin) tablets
Active Ingredient(s): ertugliflozin tablets
Dosage Form: Tablets: 5 mg and 15 mg
Medicine Approved By: Food and Drug Administration (FDA)
Manufacturer: Merck Sharp & Dohme Corp.
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “Ertugliflozin Tablets” based on the information you provide.

Everolimus Tablets

Breast Cancer, Gastrointestinal, Kidney, Lung Cancer

everolimus tablets for oral suspension
Initial U.S. Approval: 2009

Afinitor (everolimus) is a medication used to treat patients with advanced HR+, HER2- breast cancer; progressive neuroendocrine tumors of pancreatic origin (PNET); progressive neuroendocrine tumors (NET) of gastrointestinal (GI) or lung origin; advanced renal cell carcinoma; and subependymal giant cell astrocytoma (SEGA) and renal angiomyolipomas associated with tuberous sclerosis.

Facts about everolimus tablets

Disease Indications-Breast Cancer, Gastric Cancer, Kidney Cancer, Lung Cancer, Intestinal Cancer
Manufacturer-Novartis
Usage-Intravenous
Medicine Approved By-European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada Pharmaceuticals and Medical Devices Agency (PMDA) Therapeutic Goods Administration (TGA).
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “everolimus tablets” based on the information you provide.

Exenatide Injection

Diabetes

exenatide Injection
Initial U.S. Approval: 2005

BYETTA is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Facts about exenatide Injection

Approval Date: 2005
Proprietary Name: BYETTA (exenatide) Injection
Active Ingredient(s): exenatide
FDA-approved use: 2 diabetes mellitus.
Dosage Form: BYETTA is supplied as 250 mcg/mL exenatide in: • 5 mcg per dose, 60 doses, 1.2 mL prefilled pen • 10 mcg per dose, 60 doses, 2.4 mL prefilled pen.
Medicine Approved By: Food and Drug Administration (FDA)
Manufacturer: Amylin Pharmaceuticals, Inc.
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “Exenatide Injection” based on the information you provide.

« Older Entries

Next Entries »

Contact Info

CORPORATE OFFICE:
Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.

MOBILE / PHONE NUMBER:
M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398

EMAIL ID:
info@indianpharmanetwork.co.in

FAX NUMBER:
+91-11-26532129

Query Form For Medications

Note

We are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.

Disclaimer

“Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is intended to provide general information about consultancy services offered by IPN and to help users access this information in a user friendly format. Certain information available on the website has been sourced from publicly available sources. While Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in believes such information to be reasonably accurate, Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in has not independently verified any of this information. All information on the IPN website is of general nature and is not a substitute for medical prescription. None of the medicines or products mentioned on the IPN website are manufactured or sold by IPN Pharma Network.

Privacy Policy

Please read the following statement to learn about our information gathering and dissemination practices in relation to our consultancy services (“Services”). Note: Our privacy policy is subject to change at any time without notice. To make sure you are aware of any changes, please review this policy periodically. By visiting the Indian Pharma Network

Health Information

“All information available on the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is of general nature and is not a substitute for professional medical advice by a licensed practitioner. Indian Pharma Network (IPN) does not purport to provide any medical or health-related advice, even of general nature and therefore you should not use or consult the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in for any questions in relation to your health or medical condition.

Shipped Anti-Cancer Medicines.

Indian Pharma Network is registered medical pharmacy for Oncology Products in India. Helps you to access FDA approved Anti-Cancer-Medicines, no matter where you live. Sourcing each medicine for named patient use and overseeing every aspect of the shipping, customs and delivery. We have helped more than 6,000 patients. Send your enquiry to find the What is the cost of Anti Cancer Medicines in Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

Indian Pharma Network (IPN), New Delhi. India

Indian Pharma Network

60/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016

Mobile / WhatsApp / Phone
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398

Free Customer Support
info@indianpharmanetwork.co.in
urgent@indianpharmanetwork.co.in

Chronic Disease

cysteamine bitartrate delayed-release capsules, for oral use

Access the best support services globally

Brand Name: DEFENCATH Generic Name: (taurolidine, heparin) DEFENCATH (taurolidine, heparin) is used to reduce the incidence of catheter-related bloodstream infections in adults with kidney failure receiving chronic hemodialysis through a central venous catheter.

KORSUVA (difelikefalin) injection, for intravenous use Initial U.S. Approval: 2021

Facts about difelikefalin Injection

Access the best support services globally

dulaglutide injection for subcutaneous use Initial U.S. Approval: 2014

Facts about dulaglutide injection

Access the best support services globally

Brand: EGRIFTA WR. API: tesamorelin is used to treat HIV-infected adults with lipodystrophy.

Get access EGRIFTA WR to treat HIV-infected adults with lipodystrophy on a Named Patient Import Basis.

ELAHERE (mirvetuximab soravtansine-gynx) – folate receptor-alpha positive ovarian cancer, fallopian tube cancer, or primary peritoneal cancer therapy in India

Access ELAHERE for ovarian cancer, fallopian tube cancer, or primary peritoneal cancer treatment on a Named Patient Import Basis

empagliflozin and linagliptin tablets for oral use Initial U.S. Approval: 2015

Access the best support services globally

ertugliflozin tablets for oral use Initial U.S. Approval: 2017

Facts about ertugliflozin tablets

Access the best support services globally

everolimus tablets for oral suspension Initial U.S. Approval: 2009

Facts about everolimus tablets

Access the best support services globally

exenatide Injection Initial U.S. Approval: 2005

Access the best support services globally

Contact Info

Query Form For Medications

Note

Disclaimer

Privacy Policy

Health Information

Shipped Anti-Cancer Medicines.

Indian Pharma Network (IPN), New Delhi. India

cysteamine bitartrate
delayed-release capsules, for oral use

Brand Name: DEFENCATH Generic Name: (taurolidine, heparin)
DEFENCATH (taurolidine, heparin) is used to reduce the incidence of catheter-related bloodstream infections in adults with kidney failure receiving chronic hemodialysis through a central venous catheter.

KORSUVA (difelikefalin) injection,
for intravenous use Initial U.S. Approval: 2021

dulaglutide injection
for subcutaneous use Initial U.S. Approval: 2014

empagliflozin and linagliptin tablets
for oral use Initial U.S. Approval: 2015

ertugliflozin tablets
for oral use Initial U.S. Approval: 2017

everolimus tablets for oral suspension
Initial U.S. Approval: 2009

exenatide Injection
Initial U.S. Approval: 2005